IRHYTHM HOLDINGS INC (IRTC) — insider trading
Health Care · NASDAQ
IRHYTHM HOLDINGS INC (IRTC) has 39 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 19 open-market sales among the most recent 39 (latest 2026-09-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Wilson Daniel G. | Officer (Chief Financial Officer) | Open-market sale | 773 | $121.83 | $94.2K | Form 4 |
| 2026-08-10 | Turakhia Minang | Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Open-market sale | 7,093 | $124.65 | $884.2K | Form 4 |
| 2026-08-10 | Shrishrimal Sumi | Officer (EVP, Chief Risk Officer) | Open-market sale | 5,372 | $124.65 | $669.6K | Form 4 |
| 2026-08-10 | Patterson Chad | Officer (CHIEF COMM & PRODUCT OFFICER) | Open-market sale | 7,093 | $124.65 | $884.2K | Form 4 |
| 2026-08-10 | Murphy Patrick Michael | Officer (CBO and CLO) | Open-market sale | 7,093 | $124.65 | $884.2K | Form 4 |
| 2026-08-10 | Blackford Quentin S. | Director, Officer (President and CEO) | Open-market sale | 26,859 | $124.65 | $3.35M | Form 4 |
| 2026-08-07 | Turakhia Minang | Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Grant / award / vesting | 13,589 | — | $0 | Form 4 |
| 2026-08-07 | Shrishrimal Sumi | Officer (EVP, Chief Risk Officer) | Grant / award / vesting | 9,706 | — | $0 | Form 4 |
| 2026-08-07 | Patterson Chad | Officer (CHIEF COMM & PRODUCT OFFICER) | Grant / award / vesting | 13,589 | — | $0 | Form 4 |
| 2026-08-07 | Murphy Patrick Michael | Officer (CBO and CLO) | Grant / award / vesting | 13,589 | — | $0 | Form 4 |
| 2026-08-07 | Blackford Quentin S. | Director, Officer (President and CEO) | Grant / award / vesting | 48,534 | — | $0 | Form 4 |
| 2026-08-03 | Patterson Chad | Officer (CHIEF COMM & PRODUCT OFFICER) | Open-market sale | 2,712 | $122.12 | $331.2K | Form 4 |
| 2026-08-03 | Rodda Julianne | Officer (EVP, CHIEF PEOPLE OFFICER) | Open-market sale | 2,112 | $122.12 | $257.9K | Form 4 |
| 2026-08-03 | Smith Mervin | Officer (EVP Strategic Business Ops) | Open-market sale | 617 | $122.12 | $75.3K | Form 4 |
| 2026-07-02 | Freeman Sean Clinton | Officer (EVP, Strategy & Corp Devt) | Open-market sale | 918 | $124.71 | $114.5K | Form 4 |
| 2026-07-02 | Turakhia Minang | Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Open-market sale | 1,423 | $124.71 | $177.5K | Form 4 |
| 2026-06-02 | Rosenbaum Marc Wade | Officer (Chief Accounting Officer) | Open-market sale | 729 | $108.19 | $78.9K | Form 4 |
| 2026-06-02 | Shrishrimal Sumi | Officer (EVP, Chief Risk Officer) | Open-market sale | 1,716 | $108.19 | $185.7K | Form 4 |
| 2026-05-29 | Rosenbaum Marc Wade | Officer (Chief Accounting Officer) | Grant / award / vesting | 178 | $96.82 | $17.2K | Form 4 |
| 2026-05-29 | Shrishrimal Sumi | Officer (EVP, Chief Risk Officer) | Grant / award / vesting | 133 | $96.82 | $12.9K | Form 4 |
| 2026-05-29 | Blackford Quentin S. | Director, Officer (President and CEO) | Grant / award / vesting | 178 | $96.82 | $17.2K | Form 4 |
| 2026-05-29 | Freeman Sean Clinton | Officer (EVP, Strategy & Corp Devt) | Grant / award / vesting | 273 | $96.82 | $26.4K | Form 4 |
| 2026-05-29 | Patterson Chad | Officer (CHIEF COMM & PRODUCT OFFICER) | Grant / award / vesting | 177 | $96.82 | $17.1K | Form 4 |
| 2026-05-29 | Turakhia Minang | Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Grant / award / vesting | 137 | $96.82 | $13.3K | Form 4 |
| 2026-05-27 | YOOR BRIAN B | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | TALWALKAR ABHIJIT Y | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | OBOYLE KEVIN C | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | MCGINNIS KAREN K | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | Ling Karen | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | Bodaken Bruce G. | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-27 | Bairey Merz Cathleen Noel | Director | Grant / award / vesting | 1,573 | — | $0 | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Option exercise / conversion (derivative) | 5,312 | $10.71 | $56.9K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market sale | 290 | $120.53 | $35.0K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market sale | 1,147 | $119.16 | $136.7K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market sale | 2,293 | $118.02 | $270.6K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market sale | 642 | $116.98 | $75.1K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market sale | 940 | $116.05 | $109.1K | Form 4 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open-market purchase | 5,312 | $10.71 | $56.9K | Form 4 |
| 2026-05-04 | Lawrence Brian Lee | Officer (Chief Technology Officer) | Open-market sale | 1,014 | $120.80 | $122.5K | Form 4 |
Ask the chat about IRTC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: IRHYTHM HOLDINGS INC (IRTC).
Last updated 2026-09-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.